Streetbeat News

Earnings

KMX

CarMax, Inc. (NYSE:KMX) is set to release its Q4 earnings on April 11, 2024, with analysts forecasting an earnings increase to 47 cents per share from 44 cents the previous year and revenue of $5.79 billion up from $5.72 billion. Despite a 5.5% sales decline in Q3, KMX shares rose 1.7% recently. Analysts have updated their ratings, with Wedbush raising its price target to $100, while others like JP Morgan and Stephens & Co. have lowered theirs.

Portfolio Pulse from Avi Kapoor

April 09, 2024 | 3:13 pm

SNOW

A Reddit post by user Fountainheadusa has sparked a discussion on Snowflake Inc (NYSE:SNOW), with opinions divided on its investment potential. The post discusses the company's CEO transition, strategic partnerships, and financial metrics, alongside broader market dynamics. While some Redditors are optimistic about Snowflake's growth, others express concerns over its valuation and profitability. Analyst consensus on Benzinga rates Snowflake as a Buy, with Rosenblatt recently upgrading the stock to Buy with a price target of $185, indicating a potential upside.

Portfolio Pulse from Surbhi Jain

April 09, 2024 | 3:03 pm

JNJ

Johnson & Johnson (JNJ) is analyzed against its competitors in the Pharmaceuticals industry, showing mixed performance. While JNJ's PE, PB, and PS ratios suggest potential undervaluation, its low ROE, EBITDA, and gross profit indicate lower profitability and operational efficiency. However, JNJ's high revenue growth compared to industry peers highlights strong top-line performance. The company's lower debt-to-equity ratio suggests a stronger financial position relative to its top 4 peers.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 3:00 pm

LRCX

The analysis compares Lam Research (LRCX) with its competitors in the Semiconductors & Semiconductor Equipment industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. LRCX shows potential undervaluation based on its P/E ratio, strong financial performance with high ROE, EBITDA, and gross profit, but concerns arise from its significantly lower revenue growth compared to the industry average.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 3:00 pm

LULU

In the past three months, 25 analysts have reviewed Lululemon Athletica (NASDAQ:LULU), showing a mix of bullish to bearish sentiments. The average 12-month price target is now $484.6, down 7.89% from $526.10, with adjustments in ratings and price targets by several analysts. Lululemon's financial performance remains strong, with significant market capitalization, revenue growth of 15.63%, a net margin of 20.89%, ROE of 17.26%, ROA of 10.21%, and a low debt-to-equity ratio of 0.33.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 3:00 pm

VALE

Four analysts have recently reviewed Vale (NYSE:VALE), offering a mix of bullish and bearish perspectives. The average 12-month price target is now $16.62, down 12.53% from the previous average, with individual targets ranging from $13.00 to $19.00. Analysts from B of A Securities, Deutsche Bank, and RBC Capital have adjusted their ratings and price targets, reflecting changing market dynamics and company performance. Vale, a leading global miner, has shown strong financial performance with significant revenue growth, high net margin, and efficient asset and equity management.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 3:00 pm

AAPL

The analysis compares Apple (AAPL) with its competitors in the Technology Hardware, Storage & Peripherals industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Apple shows potential for growth with a lower P/E ratio than the industry average, but its high P/B and P/S ratios suggest a premium valuation. The company's strong ROE, EBITDA, and gross profit indicate robust profitability, though its revenue growth lags behind the industry average.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 3:00 pm

NSC

Norfolk Southern Corporation (NYSE:NSC) reported Q1 2024 adjusted earnings per share of $2.49, below estimates, with revenues of $3.004 billion. A significant $600 million settlement related to the East Palestine derailment class action lawsuit impacted finances, alongside $691 million in expenses from workforce cuts and other adjustments. Despite these challenges, the company sees momentum for improvement in the coming months, with operational efficiencies already showing positive results.

Portfolio Pulse from Akanksha Bakshi

April 09, 2024 | 2:56 pm

VINC

Vincerx Pharma Inc (NASDAQ:VINC) reported preliminary Phase 1 data for VIP236 and updates on its pipeline at the AACR Annual Meeting 2024. The data showed no dose-limiting toxicity and stable disease in some patients. Additionally, Vincerx presented promising preclinical results for its VersAptx platform. Despite these updates, VINC shares plummeted by 73.30% to $1.27.

Portfolio Pulse from Vandana Singh

April 09, 2024 | 2:29 pm

DVN

Significant bearish sentiment has been observed in the options market for Devon Energy (NYSE:DVN), with a notable volume of options trades indicating a price target range between $40.0 and $57.5. Despite this, expert analysts have issued positive ratings, with a consensus target price of $58.0. The company's current market performance shows a slight increase in stock price, with an upcoming earnings announcement in 22 days.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 2:16 pm